Evidence map›Paper›PMID 39982315›Full record

ArticleClocks & sleep2025

Healthcare Burden and Productivity Loss Due to Narcolepsy in Sweden.

Anna Giertz, Johan Mesterton, Tanja Jakobsson, Stephen Crawford, Somraj Ghosh, Anne-Marie Landtblom

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clocks & sleep, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Anna GiertzQuantify Research, Hantverkargatan 8, 112 21 Stockholm, Sweden.
Johan MestertonQuantify Research, Hantverkargatan 8, 112 21 Stockholm, Sweden.
Tanja JakobssonTakeda Pharma AB, Lindhagensgatan 120, 112 51 Stockholm, Sweden.
Stephen CrawfordTakeda Development Center Americas, Inc., Cambridge, MA 02142, USA.
Somraj GhoshTakeda Development Center Americas, Inc., Cambridge, MA 02142, USA.
Anne-Marie LandtblomDepartment of Medical Sciences, Uppsala University, 751 05 Uppsala, Sweden.ORCID 0000-0001-9567-470X

Funding

Takeda Pharma AB, Lindhagensgatan 20, 112 51 Stockholm NA
6 · The paper itself

Abstract

backgroundNarcolepsy impacts both patients and society, yet there is limited data on its socioeconomic consequences.

methodsThis retrospective longitudinal cohort study used pseudonymized patient-level data from Swedish registers and included narcolepsy patients from January 2015-December 2019 and age-sex matched controls. All patients received an index date corresponding to their first narcolepsy diagnosis.

resultsThis study included 466 incident narcolepsy patients and 2330 matched controls. During the years studied, healthcare resource utilization was 2-5 times higher for incident narcolepsy patients compared to matched controls (

conclusionsThis study provides evidence of the magnitude of the substantial societal economic burden due to narcolepsy in Sweden, evidenced by higher healthcare resource utilization and indirect costs.

Indexed as

costdisability leavehealthcare resource utilizationnarcolepsyPandemrix vaccinationpharmaceutical productssick leaveSwedenwork productivity loss

Identifiers

PMID39982315
PMCPMC11843934

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.